beta-alanine has been researched along with Stomach Neoplasms in 4 studies
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperammonemia is an important adverse event associated with 5-fluorouracil (5FU) from 5FU metabolite accumulation." | 7.96 | Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses. ( Funakoshi, T; Horimatsu, T; Ikeda, A; Imamaki, H; Kataoka, S; Matsubara, T; Muto, M; Nakagawa, S; Nishikawa, Y; Oura, M; Ozaki, Y; Watanabe, N; Yanagita, M; Yonezawa, A, 2020) |
| "Hyperammonemia is an important adverse event associated with 5-fluorouracil (5FU) from 5FU metabolite accumulation." | 3.96 | Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses. ( Funakoshi, T; Horimatsu, T; Ikeda, A; Imamaki, H; Kataoka, S; Matsubara, T; Muto, M; Nakagawa, S; Nishikawa, Y; Oura, M; Ozaki, Y; Watanabe, N; Yanagita, M; Yonezawa, A, 2020) |
| "In all, 10 patients with gastric cancer received PVI of 5-FU at a dose of 250 mg/m2/day for 5 days." | 1.33 | [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil]. ( Yamada, Y, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozaki, Y | 1 |
| Imamaki, H | 1 |
| Ikeda, A | 1 |
| Oura, M | 1 |
| Nakagawa, S | 1 |
| Funakoshi, T | 1 |
| Kataoka, S | 1 |
| Nishikawa, Y | 1 |
| Horimatsu, T | 1 |
| Yonezawa, A | 1 |
| Matsubara, T | 1 |
| Yanagita, M | 1 |
| Muto, M | 1 |
| Watanabe, N | 1 |
| Yamada, Y | 1 |
| Kim, WY | 1 |
| Nakata, B | 1 |
| Hirakawa, K | 1 |
| Kishida, T | 1 |
| Sannomiya, Y | 1 |
| Nakao, Y | 1 |
| Yasui, Y | 1 |
| Ota, K | 1 |
| Ohira, H | 1 |
| Inoue, T | 1 |
| Furukawa, Y | 1 |
| Yamane, T | 1 |
| Keunsik, P | 1 |
4 other studies available for beta-alanine and Stomach Neoplasms
| Article | Year |
|---|---|
Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses.
Topics: Aged, 80 and over; Ammonia; Antimetabolites, Antineoplastic; beta-Alanine; Drug Administration Sched | 2020 |
[Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Topics: beta-Alanine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Fluorouracil; Humans; Infusions | 2006 |
Alternative pharmacokinetics of S-1 components, 5-fluorouracil, dihydrofluorouracil and alpha-fluoro-beta-alanine after oral administration of S-1 following total gastrectomy.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; beta-Alanine; Drug Combinations; Fluorouracil; | 2007 |
[Clinical evaluation of panipenem/betamipron in severe infections complicating hematological disorders].
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Infections; beta-Alanine; Drug Evaluation; Dru | 1992 |